The primary objective of this study is to validate the safety and clinical performance of the ABLE Exoskeleton with integrated Functional Electrical Stimulation (ABLE FES) in individuals with neurological conditions that impair gait, including spinal cord injury, acquired brain injury, and multiple sclerosis. The secondary objective is to collect preliminary data on the potential clinical and psychosocial benefits of combining robotic gait assistance with electrical stimulation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number and type of device-related Adverse Events
Timeframe: From baseline to follow-up (up to 2 weeks after end of intervention)
Time taken to don/doff the device
Timeframe: Up to 5 weeks (8 sessions)
Number of steps walked
Timeframe: Up to 5 weeks (8 sessions)
Distance walked
Timeframe: Up to 5 weeks (8 sessions)
Time spent upright and time spent walking
Timeframe: Up to 5 weeks (8 sessions)
Number of therapists assisting the session
Timeframe: Up to 5 weeks (8 sessions)
Assistive device used
Timeframe: Up to 5 weeks (8 sessions)
Step Length
Timeframe: Up to 5 weeks (8 sessions)
Step Symmetry
Timeframe: Up to 5 weeks (8 sessions)
Center of mass displacement (cm)
Timeframe: Up to 5 weeks (8 sessions)
Motor torque (Nm)
Timeframe: Up to 5 weeks (8 sessions)